- Home
- NXPL vs SONN Comparison
NXPL vs SONN Comparison
Compare NXPL & SONN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXPL
- SONN
- Stock Information
- Founded
- NXPL 1997
- SONN N/A
- Country
- NXPL United States
- SONN United States
- Employees
- NXPL N/A
- SONN N/A
- Industry
- NXPL Telecommunications Equipment
- SONN Biotechnology: Pharmaceutical Preparations
- Sector
- NXPL Telecommunications
- SONN Health Care
- Exchange
- NXPL Nasdaq
- SONN Nasdaq
- Market Cap
- NXPL 22.8M
- SONN 21.4M
- IPO Year
- NXPL N/A
- SONN N/A
- Fundamental
- Price
- NXPL $0.76
- SONN $4.00
- Analyst Decision
- NXPL
- SONN Strong Buy
- Analyst Count
- NXPL 0
- SONN 1
- Target Price
- NXPL N/A
- SONN $20.00
- AVG Volume (30 Days)
- NXPL 343.0K
- SONN 706.5K
- Earning Date
- NXPL 11-13-2025
- SONN 08-13-2025
- Dividend Yield
- NXPL N/A
- SONN N/A
- EPS Growth
- NXPL N/A
- SONN N/A
- EPS
- NXPL N/A
- SONN N/A
- Revenue
- NXPL $58,766,000.00
- SONN $1,000,000.00
- Revenue This Year
- NXPL N/A
- SONN $5,376.22
- Revenue Next Year
- NXPL N/A
- SONN N/A
- P/E Ratio
- NXPL N/A
- SONN N/A
- Revenue Growth
- NXPL N/A
- SONN 1689.52
- 52 Week Low
- NXPL $0.43
- SONN $1.08
- 52 Week High
- NXPL $2.30
- SONN $19.30
- Technical
- Relative Strength Index (RSI)
- NXPL 43.45
- SONN 41.16
- Support Level
- NXPL $0.78
- SONN $3.87
- Resistance Level
- NXPL $1.10
- SONN $6.15
- Average True Range (ATR)
- NXPL 0.07
- SONN 0.57
- MACD
- NXPL -0.01
- SONN -0.23
- Stochastic Oscillator
- NXPL 8.11
- SONN 5.26
About NXPL NextPlat Corp
NextPlat Corp is an e-commerce and healthcare company. Its e-commerce venues form an effective network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operates in two segments: e-Commerce Operations involves acquiring and leasing an e-commerce platform; and Healthcare Operations provides TPA, data management, COVID-19 related diagnostics and vaccinations, prescription pharmaceuticals, and Others.
About SONN Sonnet BioTherapeutics Holdings Inc.
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The Company views its operations and manages its business in one segment. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.